Barclays raised the firm’s price target on Ituran (ITRN) to $50 from $35 and keeps an Overweight rating on the shares. The company reported 7% year-over-year revenue growth in Q4 and its fiscal 2025 guidance implies an acceleration in subscriber adds, the analyst tells investors in a research note. The firm raised estimates to reflect the higher growth outlook.